ipos
The IPO Market Is Roaring Back in 2026 — and the Biggest Deals May Still Be Ahead
Medline's record IPO reopened the new-issue window. With SpaceX, OpenAI and Databricks reportedly weighing listings, 2026 could top 2021.
Section
IPOs
New listings, from S-1 filing to first-day trade and beyond. We track the pipeline, the pricing and — more usefully — how debuts perform once the first-day pop fades.
Featured research
ipos
China's $8.6bn CXMT IPO Is a Test of the Semiconductor Trade
CXMT's $8.6bn Shanghai IPO drew huge demand, but weaker oversubscription shows investors are becoming more selective on chip stocks.
Related topics
Latest coverage
ipos
Revolut Company Profile: Valuation, Banking Expansion and the IPO Question
A current Revolut company profile covering its banking expansion, customer scale, private-market valuation context and the factors that will shape any future IPO.
ipos
Shein's $1.8bn Hong Kong IPO Puts a 70% Valuation Reset in Public View
Shein is targeting a valuation of up to $27bn in Hong Kong, roughly 70% below its private-market peak four years ago.